In conclusion, expression of multifunctional AKR1C3, which is known to be the most up-regulated steroidogenic enzyme in patients with CRPC, might increase with the occurrence and longitudinal progression of the tumor in certain cases [17,32]. This evidence concerns the gene AKR1C3 and neoplasm.